US EditionPublished • loading... • Updated
FDA vaccines chief Vinay Prasad to step down in April
Vinay Prasad’s tenure as FDA’s biologics chief was marked by controversies over rare disease drug scrutiny and vaccine regulation, with multiple agency rejections and leadership disputes.
- The FDA confirmed Vinay Prasad, a top official overseeing vaccines and gene therapies, will depart in April and has not named a successor.
- On 2026-03-06, the Center for Biologics Evaluation and Research increased scrutiny and rejected at least five cell and gene therapies, with a recent high-profile rejection of a rare-blood-cancer drug, amid disputes with drugmakers, and the Health and Human Services Department criticized an experimental Huntington's treatment the day before.
- Sources describe management actions that reshaped CBER's internal operations, including firing staff and demanding calendar visibility from California, after a brief ouster and rehiring in July.
- Prasad's actions produced immediate regulatory consequences, including a White House-intervened review after he refused to review a Moderna flu vaccine, and control of vaccine surveillance shifted from career staff.
- Amid a broader shift under Health Secretary Robert F. Kennedy Jr., Prasad's exit signals wider policy implications as the FDA adopts a more vaccine-skeptical approach; this is a developing story STAT will update.
Insights by Ground AI
Podcasts & Opinions
139 Articles
139 Articles
MAHA is sick: RFK’s FDA is drifting the wrong way
If Health and Human Services Secretary Robert F. Kennedy Jr. wants to be true to his word and “Make America Healthy Again,” he must reform the Food and Drug Administration. Dr. Vinay Prasad, whose actions thwart medical freedom, endanger the unborn, and compromise patient choice, needs to go now, not at the end of April.Prasad is a “Bernie Sanders acolyte” who “doesn’t think patients can be trusted to make their own healthcare decisions,” as All…
·United States
Read Full Article
Coverage Details
Total News Sources139
Leaning Left18Leaning Right10Center95Last UpdatedBias Distribution77% Center
Bias Distribution
- 77% of the sources are Center
77% Center
15%
C 77%
Factuality
To view factuality data please Upgrade to Premium
